Global X - Genomics & Biotechnology ETF (GNOM) is a publicly traded company in the Financial Services sector, operating within the Asset Management - Global industry.
GNOM has IPO date of 2019-04-10, listed on the NASDAQ Global Market, a market capitalization of $52.75M.
The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.